References
- Leigh D. Subacute Necrotizing Encephalomyelopathy in an Infant. Journal of Neurology, Neurosurgery and Psychiatry. 1951;14:216–221. DOI: 10.1136/jnnp.14.3.216
- Schubert Baldo M, Vilarinho L. Molecular basis of Leigh syndrome: a current look. Orphanet Journal of Rare Diseases. 2020;15(1):1–14. DOI: 10.1186/s13023-020-1297-9
- Piao YS, Tang GC, Yang H, Lu DH. Clinico-neuropathological study of a Chinese case of familial adult Leigh syndrome. Neuropathology. 2006;26(3):218–221. DOI: 10.1111/j.1440-1789.2006.00686.x
- Lee JS, Yoo T, Lee M, Lee Y, Jeon E, Kim SY, Lim BC, Kim KJ, Choi M, Chae JH. Genetic heterogeneity in Leigh syndrome: Highlighting treatable and novel genetic causes. Clinical Genetics. 2020;97(4):586–594. DOI: 10.1111/cge.13713
- McCormick EM, Keller K, Taylor JP, Coffey AJ, Shen L, Krotoski D, Harding B, Gai NCMDGPX, Falk MJ, Zolkipli-Cunningham Z, Rahman S. Expert Panel Curation of 113 Primary Mitochondrial Disease Genes for the Leigh Syndrome Spectrum. Annals of Neurology. 2023;94(4):696–712. DOI: 10.1002/ana.26716
- Magro G, Laterza V, Tosto F. Leigh Syndrome: A Comprehensive Review of the Disease and Present and Future Treatments. Biomedicines. 2025;13(3):1–26. DOI: 10.3390/biomedicines13030733
- Chang X, Wu Y, Zhou J, Meng H, Zhang W, Guo J. A meta-analysis and systematic review od Leigh syndrome: clinical manifestations, respiratory chain enzyme complex deficiency, and gene mutations. Medicine. 2020;99(5):1–6. DOI: 10.1097/MD.0000000000018634
- Lake NJ, Compton AG, Rahman S, Thorburn DR. Leigh Syndrome: One Disorder, More Than 75 Monogenic Causes. Annals of Neurology. 2016;79(2):190–203. DOI: 10.1002/ana.24551
- Hong C-M, Na JH, Park S, Lee YM. Clinical Characteristics of Early-Onset and Late-Onset Leigh Syndrome. Frontiers in Neurology. 2020;11(267):1–8. DOI: 10.3389/fneur.2020.00267
- Huntsman RJ, Sinclair DB, Bhargava R, Chan A. Atypical Presentations of Leigh Syndrome: A Case Series and Review. Pediatric Neurology. 2005;32(5):334–340. DOI: 10.1016/j.pediatrneurol.2004.12.009
- Rahman S.
Chapter 4 – Leigh syndrome . In: Handbookof Clinical Neurology, Elsevier; 2023. pp. 43–63. DOI: 10.1016/B978-0-12-821751-1.00015-4 - Yigit G, Sheffer R, Daana M, Li Y, Kaygusuz E, Mor-Shakad H, Altmüller J, Nürnberg P, Douiev L, Kaulfuss S, Burfeind P, Wollnik B, Brockmann K. Loss-of-function variants in DNM1 cause a specific form of developmental and epileptic encephalopathy only in biallelic state. Neurogenetics. 2022;59(6):549–553. DOI: 10.1136/jmedgenet-2021-107769
- John A, Ng-Cordell E, Hanna N, Brkic D, Baker K. The neurodevelopmental spectrum of synaptic vesicle cycling disorders. Journal of Neurochemistry. 2020;157(2):208–228. DOI: 10.1111/jnc.15135
- Zaha K, Matsumoto H, Itoh M, Saitsu H, Kato K, Kato M, Ogata S, Murayama K, Kishita Y, Mizuno Y, Kohda M, Nishino I, Ohtake A, Okazaki Y, Matsumoto N, Nonoyama S. DNM1L-related encephalopathy in infancy with Leigh syndrome-like phenotype and suppression-burst. Clinical genetics. 2016;90(5):472–474. DOI: 10.1111/cge.12805
- Ferguson SM, De Camilli P. Dynamin, a membrane-remodeling GTPase. Nature Reviews. Molecular Cell Biology. 2012;13(2):75–88. DOI: 10.1038/nrm3266
- von Spiczak S, Helbig KL, Shinde DN, Huether R, Dipl-Biol MP, Lourenço C, Nunes ME, Sarco DP, Kaplan RA, Dlugos DJ, Kirsch H, Slavotinek A, Cilio MR, Cervenka MC, Cohen JS, McClellan R, Fatemi A, Yuen A, Sagawa Y, Littlejohn R, McLean SD, Hernandez-Hernandez L, Maher B, Møller RS, Palmer E, Lawson JA, Campbell CA, Joshi CN, Kolbe DL, Hollingsworth G, Neubauer BA, Muhle H, Stephani U, Scheffer IE, Pena SDJ, Sisodiya SM, Helbig I. DNM1 encephalopathy. A new disease of vesicle fission. Neurology. 2017;89(4):385–394. DOI: 10.1212/WNL.0000000000004152
- Brereton E, Fassi E, Araujo GC, Dodd J, Telegrafi A, Pathak SJ, Shinawi M. Mutations in the PH Domain of DNM1 are associated with a nonepileptic phenotype characterized by developmental delay and neurobehavioral abnormalities. Molecular Genetics & Genomic Medicine. 2018;6(2):394–300. DOI: 10.1002/mgg3.362
- Baertling F, Rodenburg RJ, Schaper J, Smeitink JA, Koopman WJH, Mayatepek E, Morava E, Distelmaier F. A guide to diagnosis and treatment of Leigh syndrome. Journal of neurology, neurosurgery, and psychiatry. 2014;85(3):257–265. DOI: 10.1136/jnnp-2012-304426
- Choi E, Dale B, RamachandranNair R, Ejaz R. Pathogenic DNM1 Gene Variant Presenting With Unusually Nonsevere Neurodevelopmental Phenotype: A Case Report. Neurology Genetics. 2021;7(5):1–4. DOI: 10.1212/NXG.0000000000000618
- Calvo J, Funalot B, Ouvrier R, Lazaro L, Toutain A, De Mas P, Bouche P, Gilbert-Dussardier B, Arne-Bes M-C, Carrière J-P, Journel H, Minot-Myhie M-C, Guillou C, Ghorab K, Magy L, Sturtz F, Vallat J-M, Magdelaine C. Genotype-Phenotype Correlations in Charcot-Marie-Tooth Disease Type 2 Caused by Mitofusin 2 Mutations. Archives of Neurology. 2009;66(12):1511–1516. DOI: 10.1001/archneurol.2009.284
- Pipis M, Feely SME, Polke JM, Skorupinska M, Perez L, Shy RR, Laura M, Morrow JM, Moroni I, Pisciotta C, Taroni F, Vujovic D, Lloyd TE, Acsadi G, Yum SW, Lewis RA, Finkel RS, Herrmann DN, Day JW, Li J, Saporta M, Sadjadi R, Walk D, Burns J, Muntoni F, Ramchandren S, Hovarth R, Johnson NE, Züchner S, Pareyson D, Scherer SS, Rossor AM, Shy ME, Reilly MM. Natural history of Charcot-Marie-Tooth disease type 2A: a large international multicentre study. Brain. 2020;143(12):3589–3602. DOI: 10.1093/brain/awaa323
- Abati E, Manini A, Velardo D, Del Bo R, Napoli L, Rizzo F, Moggio M, Bresolin N, Bellone E, Bassi MT, D’Angelo MG, Comi GP, Corti S. Clinical and genetic features of a cohort of patients with MFN2-related neuropathy. Scientific reports. 2022;12(1):6181. DOI: 10.1038/s41598-022-10220-0
- Boaretto F, Vettori A, Casarin A, Vazza G, Muglia M, Rossetto MG, Cavallaro T, Rizzuto N, Carelli V, Salviati L, Mostacciuolo ML, Martinuzzi A. Severe CMT Type 2 With Fatal Encephalopathy Associated With a Novel MFN2 Splicing Mutation. Neurology. 2010;74(23):1919–1921. DOI: 10.1212/WNL.0b013e3181e240f9
- National Center for Biotechnology Information.
National Library of Medicine . ClinVar. 16 March 2025. [Online]. Available:https://www.ncbi.nlm.nih.gov/clinvar/RCV000692017/ . [Accessed 17 March 2025]. - Laššuthová P, Brožková DŠ, Krůtová M, Neupauerová J, Haberlová J, Mazanec R, Dřímal P, Seeman P. Improving diagnosis of inherited peripheral neuropathies through gene panel analysis. Orphanet Journal of Rare Diseases. 2016;11(1):1–10. DOI: 10.1186/s13023-016-0500-5
- Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho Y-Y, Kobayashi Y, Patil N, Thusberg J, Westbrook M, The Invitae Clinical Genomics Group, Topper S. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genetics in Medicine. 2017;19(10):1105–1117. DOI: 10.1038/gim.2017.37
- Lake NJ, Webb BD, Stroud DA, Richman TR, Ruzzenente B, Compton AG, Mountford HS, Pulman J, Zangarelli C, Rio M, Boddaert N, Assouline Z, Sherpa MD, Schadt EE, Houten SM, Byrnes J, McCormick EM, Zolkipli-Cunningham Z, Haude K, Zhang Z, Retterer K, Bai R, Calvo SE, Mootha VK, Christodoulou J, Rötig A, Filipovska A, Cristian I, Falk MJ, Metodiev MD, Thorburn DR. Biallelic Mutations in MRPS34 Lead to Instability of the Small Mitoribosomal Subunit and Leigh Syndrome. The American Journal of Human Genetics. 2017;101(2):239–254. DOI: 10.1016/j.ajhg.2017.07.005
- Rivas MA, Pirinen M, Conrad DF, Lek M, Tsang EK, Karczewski KJ, Maller JB, Kukurba KR, DeLuca DS, Fromer M, Ferreira PG, Smith KS, Zhang R, Zhao F, Banks E, Poplin R, Ruderfer DM, Purcell SM, Tukiainen T, Minikel EV, Stenson PD, Cooper DN, Huang KH, Sullivan TJ, Nedzel J, The GTEx Consortium, The Geuvadis Consortium, Bustamante CD, Li JB, Daly MJ, Guigo R, Donnelly P, Ardlie K, Sammeth M, Dermitzakis ET, McCarthy MI, Montgomery SB, Lappalainen T, MacArthur DG. Effect of predicted protein-truncating genetic variants on the human transcriptome. Human Genomics. 2015;348(6235):666–669. DOI: 10.1126/science.1261877
- Aniello MS, Martino D, Petruzzella V, Eleopra R, Mancuso M, Dell’Aglio R, Cavallo M, Siciliano G, Defazio G. Bilateral Striatal Necrosis, Dystonia and Multiple Mitochondrial DNA Deletions: Case Study and Effect of Deep Brain Stimulation. Movement Disorders: official journal of the Movement Disorders Society. 2008;23(1):114–118. DOI: 10.1002/mds.21760
- Pelzer E, Pauls AKM, Binder E, Brunn A, Fink GR, Timmermann L. Deep brain stimulation in rapidly progressive parkinson-dystonia syndrome due to mitochondrial disorder. Parkinsonism and Related Disorders. 2012;18(5):672–674. DOI: 10.1016/j.parkreldis.2011.10.012
- Kovacs N, Pal E, Balas I, Janszky J, Nagy F, Merkli H. Neurosurgical Treatment of Tremor in Mitochondrial Encephalopathy. Movement Disorders: offial journal of the Movement Disorder Society. 2006;21(12):2227–2230. DOI: 10.1002/mds.21128
- Zúñiga-Ramírez C, Kramis-Hollands M, Mercado-Pimentel R, González-Usigli HA, Sáenz-Farret M, Soto-Escageda A, Fasano A. Generalized Dystonia and Paroxysmal Dystonic Attacks due to a Novel ATP1A3 Variant. Tremor and Other Hyperkinetic Movements. 2019;13(9). DOI: 10.5334/tohm.490
- Zangiabadi N, Ladino LD, Sina F, Orozco-Hernández JP, Carter A, Téllez-Zenteno JF. Deep Brain Stimulation and Drug-Resistant Epilepsy: A Review of the Literature. Frontiers in Neurology. 2019;10(601):1–18. DOI: 10.3389/fneur.2019.00601
- Okromelidze L, Tsuboi T, Eisinger RS, Burns MR, Charbel M, Rana M, Grewal SS, Lu CQ, Almeida L, Foote KD, Okun MS, Middlebrooks EH. Functional and Structural Connectivity Patterns Associated with Clinical Outcomes in Deep Brain Stimulation of the Globus Pallidus Internus fro Generalized Dystonia. AJNR. American Journal of Neuroradiology. 2020;41(3):508–514. DOI: 10.3174/ajnr.A6429